FDA Requirements for Label Design: A Quick Review

A single label error can pull a product off shelves, trigger a recall, and expose a brand to federal enforcement — all before a single consumer complaint comes in.

Understanding FDA requirements for label design is not optional for anyone producing packaged food, OTC drugs, dietary supplements, or medical devices sold in the US.

The rules span multiple federal laws, including the FD&C Act and the Fair Packaging and Labeling Act, and cover everything from principal display panel layout to allergen declaration placement and Nutrition Facts formatting.

This article breaks down every major label compliance requirement, category by category, so you know exactly what belongs on your label, where it goes, and what happens when it is missing.

What Are FDA Requirements for Label Design?

FDA label design requirements are mandatory content and format standards that govern what must appear on a product’s physical container and any written material accompanying it, enforced under the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the Fair Packaging and Labeling Act (FPLA).

Non-compliance is not a paperwork problem. It is a prohibited act under 21 USC 343, and every misbranded unit in commerce counts as a separate violation.

There were 506 FDA food recalls in 2023, a five-year high representing a 19.6% increase over 2022 (Sedgwick, 2024). A significant share of those events traced back to labeling failures.

What Products Fall Under FDA Labeling Jurisdiction

FDA labeling jurisdiction covers 4 primary product categories: conventional foods, dietary supplements, OTC drugs, and medical devices.

Cosmetics fall under FDA authority through the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). Meat, poultry, and certain egg products are regulated by USDA FSIS, not FDA.

Each category has its own panel format, content rules, and type size requirements set out in 21 CFR. The regulations do not overlap cleanly. A product marketed as both a food and a drug — like a fortified beverage with disease claims — must satisfy both sets of requirements simultaneously.

Label vs. Labeling: The Legal Distinction

These two terms carry different legal weight under 21 CFR 1.3.

Label: Physical written, printed, or graphic matter on the container itself.

Labeling: All written material accompanying a product — inserts, websites, brochures, point-of-sale materials. Courts have ruled that material displayed near a product at retail qualifies as labeling even without direct physical attachment.

This distinction matters because misbranding violations can arise from off-label materials, not just the container. A company whose website makes an unapproved drug claim about a food product has a labeling problem, even if the physical label is fully compliant.

What Are the Principal Display Panel Requirements?

The principal display panel (PDP) is the portion of the label most likely to be displayed or examined under normal retail conditions, as defined in 21 CFR 101.1. It must carry the statement of identity and the net quantity of contents — both with specific type size and placement rules.

Statement of Identity Placement Rules

The statement of identity is the product’s name. It must appear in bold type on the PDP, sized to be reasonably proportional to the most prominent printed matter on that panel (21 CFR 101.3).

It cannot be a trade name alone. “Sunshine Blend” is not a statement of identity. “Granola” or “Flavored Granola Cereal” is.

If the product has a standard of identity established in 21 CFR Parts 131-169, the name from that standard is required. Using a descriptive or fanciful name instead constitutes misbranding under section 403(b) of the FD&C Act.

Net Quantity of Contents: Type Size and Dual Declaration

Type size for net quantity scales with PDP area. 4 thresholds apply:

• Under 5 sq in: 1/16 inch minimum
• 5 to 25 sq in: 1/8 inch minimum
• 25 to 100 sq in: 3/16 inch minimum
• Over 100 sq in: 1/4 inch minimum

Both metric and US customary units must appear. Liquids are declared by fluid volume. Solids and semi-solids are declared by weight. The “about” qualifier is only permitted for random-weight packages. Everything else requires an exact declaration.

What Are the Information Panel Requirements?

The information panel is the label surface immediately to the right of the PDP. Under 21 CFR 101.2, it carries the required information that does not appear on the PDP, in a fixed order, with no intervening non-required material.

Required elements must appear in this sequence: nutrition labeling, ingredient list, allergen statement, name and place of business.

Vignettes, promotional copy, and brand messaging cannot interrupt this sequence. If they appear between required elements, the label is misbranded regardless of whether all required information is otherwise present.

Manufacturer and Distributor Name and Address Rules

The label must carry the name and address of the manufacturer, packer, or distributor. If the firm named is not the actual manufacturer, a qualifying phrase is required: “Manufactured for…” or “Distributed by…”

Address format: street address (may be omitted if the firm is listed in a current city directory or phone book), city, state, and ZIP code. The country must be included for imported products.

Ordering Requirements for Information Panel Elements

No intervening material rule: Once a required element appears on the information panel, the next required element must follow it without any non-required content in between.

This is where a lot of packaging design decisions create compliance problems. Designers often place promotional callouts or secondary graphics between the ingredient list and allergen statement. That arrangement violates 21 CFR 101.2(e) regardless of how minor the intervening element looks.

The FDA does not pre-approve food labels. Compliance is the manufacturer’s responsibility. Discovering the violation happens at inspection or after a consumer complaint — neither is a good time.

What Are the Nutrition Facts Label Design Requirements?

The Nutrition Facts panel format is governed by 21 CFR 101.9 and was last substantively revised in the 2016 final rule. Manufacturers with $10 million or more in annual food sales were required to comply by January 1, 2020. Manufacturers with less than $10 million had until January 1, 2021 (FDA, 2020).

The panel follows a strict typographic hierarchy. Getting the sizing wrong — even slightly — is a label compliance failure.

Serving Size and RACC Definitions

RACC stands for Reference Amount Customarily Consumed. It is the basis for the serving size declaration and is set by FDA regulation for approximately 150 food categories in 21 CFR 101.12.

Serving size is not what the manufacturer recommends. It reflects what people actually eat in one sitting.

For packages that contain between 1 and 2 servings (like a 20 oz soda), the entire package must be labeled as a single serving. For packages between 2 and 3 servings that could reasonably be consumed at once, dual-column labeling is required — one column per serving, one column per package.

Permitted Alternate Nutrition Facts Formats

5 alternate formats are permitted under 21 CFR 101.9(d):

• Standard vertical format (default)
• Tabular format (for packages where vertical format does not fit)
• Linear format (for very small packages)
• Simplified format (when 8+ nutrients are zero)
• Aggregate format (for multi-variety packages)

Choosing a format is not purely a design decision. Each alternate format has specific eligibility criteria. Using a simplified format when the product does not qualify is a labeling violation.

Type Size Hierarchy Within the Nutrition Facts Box

The 2016 rule set specific point sizes for each element. The 3 most scrutinized:

Bold formatting is required on the calorie amount, serving size declaration, and “% Daily Value” line. Hairline rules separate nutrient groups. The footnote must read: “*The % Daily Value tells you how much a nutrient in a serving of food contributes to a daily diet. 2,000 calories a day is used for general nutrition advice.”

Any deviation from specified formatting — even a font substitution that changes the rendered size — constitutes non-compliance.

What Are the Ingredient List Requirements?

Ingredients are listed in descending order of predominance by weight, using the common or usual name of each ingredient, under 21 CFR 101.4. Trade names are not acceptable substitutes.

This sounds straightforward. It gets complicated fast with multi-component ingredients.

Sub-ingredient Parenthetical Declaration Rules

When a multi-component ingredient makes up 2% or less of the finished product, its sub-ingredients may be listed in a simplified form. Above 2%, each sub-ingredient must be declared in parentheses immediately following the ingredient name.

Example: “Enriched flour (wheat flour, niacin, reduced iron, thiamine mononitrate, riboflavin, folic acid)”

The parenthetical sub-ingredient list follows the same descending-weight rule as the main ingredient list. Getting the order wrong inside the parentheses is a violation of 21 CFR 101.4(b)(2).

Collective Labeling of Spices, Flavors, and Colors

3 collective terms are permitted under specific conditions:

Spices: May be declared collectively as “spices” unless the spice is also an allergen source.

Natural flavor / Artificial flavor: Permitted collectively. If both are present, both terms must appear.

Colors: Artificial colors cannot be grouped. Each must be declared by its certified name (e.g., “FD&C Red No. 40”). Natural colors may be declared individually or collectively as “natural color.”

Bimbo Bakeries received an FDA warning letter in June 2024 specifically over food allergen labeling concerns — a real-world example of how ingredient declaration errors translate directly into enforcement action (FDA, 2024).

What Are the Food Allergen Labeling Requirements?

Food allergen declaration is one of the most actively enforced areas of FDA label compliance. The 9 major allergens — milk, eggs, fish, crustacean shellfish, tree nuts, peanuts, wheat, soybeans, and sesame — must be declared on all FDA-regulated packaged foods.

At the time FALCPA passed in 2004, the original 8 allergens accounted for over 90% of documented food allergies and serious allergic reactions in the US (FDA). Sesame became the 9th major allergen under the FASTER Act of 2021, with a mandatory compliance date of January 1, 2023.

FALCPA vs. FASTER Act: What Changed

The FASTER Act is self-implementing. FDA did not need to publish a separate regulation. The sesame allergen declaration requirement applied automatically to all products entering interstate commerce on or after January 1, 2023.

An unintended consequence: several major food brands — including Kroger, Wegmans, and Wonder Bread — responded by intentionally adding small amounts of sesame to recipes they could not verify were sesame-free, rather than risk undeclared allergen violations (Wikipedia, FALCPA article, 2023).

“Contains” Statement vs. Parenthetical Declaration

2 methods satisfy FALCPA and FASTER Act declaration requirements:

Parenthetical method: Identify the allergen source in parentheses within the ingredient list. Example: “lecithin (soy)”

“Contains” statement: Place a “Contains: [allergen list]” statement immediately after or adjacent to the ingredient list.

Both methods are valid. They cannot be mixed inconsistently. If a product uses both methods, every major allergen present must appear in both places. A “Contains” statement that omits one allergen while the ingredient list correctly identifies it does not satisfy the requirement — the “Contains” statement must be complete.

The allergen statement cannot be placed elsewhere on the label. It must be adjacent to the ingredient list (21 CFR 101.4 and FALCPA Section 403A).

What Are the Type Size and Legibility Requirements?

Legibility is a compliance requirement, not just a design preference. Under 21 CFR 101.15, all required label information must appear with “such conspicuousness (as compared with other words, statements, designs, or devices on the label or labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.”

FDA does not specify a contrast ratio. “Conspicuous” is the legal standard, and it is applied by inspectors based on real-world readability.

Minimum Type Size Rules by Package Size

2 thresholds govern minimum type size for required information:

Packages with 5 or more square inches of total surface area: 1/16 inch (approximately 6-point type) minimum for all required information.

Packages with less than 5 square inches of total surface area: 1/32 inch minimum. These packages may also qualify for alternate label formats under 21 CFR 101.2(c).

This is not the same as the net quantity type size requirement, which scales with PDP area. The general legibility rule applies to the entire label. The net quantity rule imposes additional, stricter requirements specifically for the quantity declaration.

Contrast, Type Style, and Prohibited Practices

Background contrast: Required information must appear on a contrasting background. White text on a light background fails the conspicuousness standard even if the type size is technically compliant.

Type style: Upper and lower case is required as the default. All-caps is permitted only where it does not reduce legibility. Script or ornamental fonts that reduce readability can constitute a violation even at compliant point sizes.

Good typography practice and FDA compliance overlap here more than most designers expect. The typographic hierarchy used in a label design directly affects whether required information is rendered conspicuous or buried.

Understanding visual hierarchy in the context of FDA labels means knowing that decorative elements — a strong focal point created by large brand imagery, for example — cannot visually suppress required text to the point where it fails the conspicuousness standard.

A label printed in CMYK where the background hue is too close in saturation to the text color creates a contrast problem that goes beyond aesthetics. It is a compliance risk. The same applies to gradient backgrounds that shift from dark to light across the panel — if any portion of required text sits on a section of the gradient that reduces legibility, the label is potentially non-compliant.

Working at correct DPI for print production matters here too. Text that renders crisply at high resolution can become unreadable if the file is prepared at screen resolution and printed. For color-critical label work, Pantone spot colors or a calibrated CMYK workflow give more predictable results on press than RGB files converted at the last step.

What Are the Net Quantity of Contents Declaration Rules?

Net quantity declaration errors are among the most common misbranding triggers. The rules under 21 CFR 101.7 are specific and leave little room for interpretation.

Liquids are declared by fluid volume. Solids and semi-solids are declared by weight. Mixed products follow the dominant component type.

When the net weight is expressed on the label, the prefatory term “Net Wt.” or “Net weight” is required. For fluid measure, “Net” or “Net Contents” is optional. Getting this detail wrong is a misbranding violation even when the quantity itself is accurate (OFW Law, 2015).

Net Quantity Placement and Type Size Rules

The declaration must appear in the bottom 30% of the PDP, parallel to the base on which the package rests.

The 4 type size thresholds based on PDP area (21 CFR 101.7):

• Under 5 sq in: 1/16 inch minimum
• 5 to 25 sq in: 1/8 inch minimum
• 25 to 100 sq in: 3/16 inch minimum
• Over 100 sq in: 1/4 inch minimum

On cylindrical packages, PDP area is calculated at 40% of height multiplied by circumference. Rectangular packages use full height x width of the primary display face.

Dual Declaration and Unit Measurement Rules

Both metric and US customary units are required. The declaration must use the largest appropriate unit of measure. A product weighing 24 oz must be expressed as “1.5 lb” or “1 lb 8 oz,” not simply “24 oz” (OFW Law, 2015).

“About” qualifiers are only permitted for random-weight packages. All other products require an exact declaration.

For multi-unit retail packages, the label must state: the number of individual units, the quantity of each unit, and the total combined quantity in parentheses.

What Are the OTC Drug Label Design Requirements?

The Drug Facts panel is one of the most format-specific label requirements in FDA regulation. Every OTC drug product, with limited exceptions, must comply with 21 CFR 201.66. All OTC drug products except sunscreens had to comply with the Drug Facts rule by June 2005. Sunscreens followed in December 2012 (FDA Office of Management and Budget, 2012).

FDA estimated during rulemaking that 6.4% of all OTC shelf-keeping units had labels that could not fit the Drug Facts format without packaging changes (Federal Register, 1999).

Drug Facts Panel Section Order and Type Size Rules

The 9 sections must appear in fixed order. No reordering is permitted.

“Drug Facts” header: must capitalize only the first letters of “Drug” and “Facts.” All section headings use an initial capital letter for the first word only.

Content type minimum is 6-point. Hairline rules separate all sections. The “Warnings” heading and its subheadings require bold type.

Small Package Exemptions for OTC Labels

If Drug Facts labeling requires more than 60% of the total surface area available for labeling, a modified format applies under 21 CFR 201.66(d)(10).

Modified format options:

• Reduced type to 6-point minimum
• Reduced leading and type spacing
• Use of a peel-back or extended label
• Alternative packaging configuration

Manufacturers can also submit a formal exemption request to FDA citing inapplicability, impracticability, or public health grounds. Each request covers one product and must be submitted in triplicate to FDA’s Docket No. 98N-0337.

What Are the Medical Device Labeling Requirements?

Medical device label design operates under a different regulatory framework than food. 21 CFR Part 801 governs all device labeling. 21 CFR Part 820 section 820.120 adds quality system controls requiring labeling to remain legible under all conditions of processing, storage, and distribution.

The device labeling compliance picture is active: the food and cosmetics industries recorded a 1,540-inspection increase from 2024 to 2025, and the device industry saw upticks in both warning letters and inspections (Reed Smith, 2025).

UDI Label Placement and Format Rules

Most Class II and Class III devices must bear a Unique Device Identifier. The UDI must appear in 2 forms on the label: human-readable plain text and an Automatic Identification and Data Capture (AIDC) format such as a 1D barcode, 2D DataMatrix, or RFID (FDA, 21 CFR 801).

The UDI has 2 components:

Device Identifier (DI): Fixed portion identifying the specific version or model and the labeler.

Production Identifier (PI): Variable portion carrying lot number, serial number, expiration date, or manufacturing date when those appear on the label.

Devices labeled on or after September 24, 2023, must comply with all current UDI requirements. Legacy FDA identification numbers (NDC and NHRIC) are no longer permitted on device labels from that date forward (FDA, 2022).

FDA-Recognized Symbols vs. Custom Symbols

Device labels frequently use graphical symbols to communicate warnings, sterility, storage conditions, and single-use status. FDA policy requires that any symbol on a device label either comes from an FDA-recognized standard or is explained in a symbols glossary on the label or in accompanying labeling.

The primary recognized standard is ISO 15223-1. Symbols from this standard may be used without explanation. Any symbol not in a recognized standard requires a plain-text definition adjacent to it or in a separate glossary document.

Using unrecognized symbols without a glossary is a misbranding violation under 21 CFR 801.15. This catches a lot of device manufacturers who adapt symbols from European CE-marking requirements without checking FDA recognition status.

What Are the Dietary Supplement Label Requirements?

Dietary supplement labeling follows 21 CFR 101.36, not the Nutrition Facts rules. The panel is titled “Supplement Facts,” uses a different nutrient hierarchy, and has its own serving declaration and Daily Value requirements.

The supplement market carries significant enforcement attention. An HHS Office of Inspector General report found that FDA lacks statutory authority to review structure/function claim substantiation before products hit shelves, and recommended expanding market surveillance to enforce disclaimer requirements (OIG, HHS).

Supplement Facts Panel vs. Nutrition Facts Panel: Key Differences

Dietary ingredients with no established DV are still required on the panel. They appear in a separate section below the DV column, with a dagger symbol referencing the footnote: “Daily Value not established.”

Structure/Function Claims and the Required Disclaimer

Structure/function claims do not require FDA pre-approval. The manufacturer needs substantiation that the claim is truthful and must notify FDA within 30 days of first marketing the product with the claim (21 CFR 101.93).

The required disclaimer reads: “This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”

The disclaimer must appear in boldface type, boxed separately from other text, on the same label panel as the claim. As of late 2025, FDA announced enforcement discretion allowing the disclaimer to appear once per label with an asterisk linking to claims on other panels, rather than repeating it on every panel (NutraIngredients, 2025).

What Label Claims Require FDA Pre-Approval?

Not all label claims are equal from a regulatory standpoint. Some are self-affirmed by the manufacturer. Others require FDA authorization before they can appear on a label. Using the wrong claim type, or the right claim type incorrectly, results in misbranding.

FDA permits 12 authorized health claims supported by significant scientific agreement, specified in 21 CFR 101 Subpart E (CIRS Group, 2024). Using language that implies a disease relationship without meeting one of these pathways makes the product an unapproved drug.

Authorized Health Claims vs. Qualified Health Claims

Authorized health claims: Require formal FDA petition demonstrating “significant scientific agreement.” Once approved, they may be used without a disclaimer.

Qualified health claims: Permitted via FDA enforcement discretion letters when evidence is credible but not conclusive. Must carry an agency-approved disclaimer describing the level of evidence.

In March 2024, FDA issued its first-ever qualified health claim for yogurt and reduced risk of type 2 diabetes, after reviewing 28 observational studies identified in a comprehensive literature search (FDLI, 2024). That claim requires a specific disclaimer and cannot be used on yogurts that exceed disqualifying levels of total fat (13g), saturated fat (4g), cholesterol (60mg), or sodium (480mg) per RACC.

Nutrient Content Claim Definitions and Thresholds

Nutrient content claims are self-affirmed but must meet FDA-defined criteria in 21 CFR 101 Subpart D. No pre-approval required, but non-compliant use is misbranding.

3 common threshold examples:

• “High” or “Excellent source of”: 20% or more of the DV per RACC
• “Low fat”: 3g or less per RACC and per 50g for foods with a small RACC
• “Free” (any nutrient): Nutritionally insignificant amount — defined specifically for each nutrient in 21 CFR 101.60-101.67

On December 27, 2024, FDA published a final rule updating the “healthy” implied nutrient content claim, shifting from individual nutrient thresholds to a food group and dietary pattern framework aligned with the 2020-2025 Dietary Guidelines (FDLI, 2025). Mandatory compliance applies from February 25, 2028.

What Are the Enforcement Consequences for Non-Compliant Label Design?

Label compliance failures have real consequences. FDA warning letters averaged 51 per month in the first 8 months of 2025, compared to 49 per month in 2024 and 47 in 2023 (FDLI, 2025). FDA conducted 694 more inspections in fiscal year 2025 than in 2024 (Reed Smith, 2025).

Non-compliance is not a self-correcting problem. Only 11.7% of warning letters reviewed in a 2025 FDLI analysis had received close-out letters, indicating widespread failure to complete corrective action (FDLI, 2025).

Warning Letters and the Inspection-to-Letter Timeline

FDA issues a warning letter on average 124 days after the inspection that identified the violation (FDLI, 2025). Companies often interpret the absence of a letter within 30 working days as a positive sign. It is not.

The correct read is the Form FDA 483, which documents inspectional observations at the close of the inspection. If a 483 lists labeling concerns, a warning letter for those same issues is likely regardless of timing.

Misbranding, Recalls, and Civil Penalties Under the FD&C Act

Misbranding under 21 USC 343 is a prohibited act. Each misbranded unit in commerce is a separate violation.

Over the 20-year period from 2002 to 2023, more than 35,000 individual product recalls were recorded in FDA data, with allergens and biological contamination accounting for 76% of them (ScienceDirect, 2024). Mislabeling and misbranding drove a portion of the remaining processing-related events.

The food packaging design decisions made early in a product’s development — choices about print design layout, color palette, and how white space is used around required text — directly affect whether a label clears compliance review or triggers enforcement.

A well-designed label uses visual hierarchy to make required information easy to find, not to suppress it. Alignment of information panel elements keeps required sections in the legally required order. Contrast between background and text is not just a design preference — it is a conspicuousness requirement under 21 CFR 101.15.

Understanding graphic design principles in the context of label compliance means knowing where aesthetics and regulation intersect. A logo that dominates the PDP, vector graphics that crowd the information panel, or decorative font choices that reduce legibility below the 1/16-inch standard can all contribute to a non-compliant label, regardless of how strong the design looks in isolation.

Files prepared as print-ready documents with correct bleed and safe zone settings reduce the chance that required text gets cut off during the physical printing and cutting process. These are not advanced topics — they are baseline print design practices that affect compliance in ways that are easy to miss until the label is already on shelves.

FAQ on FDA Requirements for Label Design

What information is required on a food product label?

Every FDA-regulated food label must carry a statement of identity, net quantity of contents, ingredient list in descending weight order, allergen declaration, Nutrition Facts panel, and the name and address of the manufacturer, packer, or distributor under 21 CFR 101.

What is the principal display panel and what goes on it?

The principal display panel is the portion of the label most likely seen at retail. It must carry the statement of identity and net quantity of contents, placed in the bottom 30% of the panel, in compliant type sizes per 21 CFR 101.1.

Does the FDA pre-approve food labels before a product goes to market?

No. FDA does not pre-approve food labels. Compliance is entirely the manufacturer’s responsibility. Violations are identified through inspections, consumer complaints, or market surveillance, and can result in warning letters, recalls, or misbranding action under 21 USC 343.

What are the 9 major food allergens that must be declared?

The 9 major allergens are milk, eggs, fish, crustacean shellfish, tree nuts, peanuts, wheat, soybeans, and sesame. Sesame was added as the ninth allergen under the FASTER Act of 2021, with mandatory labeling effective January 1, 2023, for all products entering interstate commerce.

What is the difference between a Nutrition Facts panel and a Supplement Facts panel?

The Supplement Facts panel is required on dietary supplements under 21 CFR 101.36, while Nutrition Facts applies to conventional foods under 21 CFR 101.9. Key differences include serving unit format, Daily Value column requirements, and how dietary ingredients without established DVs are listed.

What type size is required on food labels?

For packages with 5 or more square inches of total surface area, required information must appear in 1/16-inch minimum type. Packages under 5 square inches may use 1/32-inch type. Net quantity declarations follow separate, stricter type size rules that scale with principal display panel area.

What claims require FDA approval before appearing on a label?

Authorized health claims require FDA petition and proof of significant scientific agreement before use. Qualified health claims need an FDA enforcement discretion letter. Structure/function claims on dietary supplements do not require pre-approval but must be notified to FDA within 30 days of first marketing.

What happens if a product label is non-compliant with FDA regulations?

Non-compliance constitutes misbranding under the FD&C Act. Each misbranded unit in commerce is a separate violation. FDA enforcement tools include warning letters, mandatory recalls under FSMA, injunctions, product seizure, and criminal prosecution for willful or repeat violations under 21 USC 332-333.

What are the Drug Facts panel requirements for OTC products?

All OTC drug products must carry a Drug Facts panel under 21 CFR 201.66. Nine sections must appear in fixed order, including active ingredients, warnings, and directions. Minimum content type size is 6-point. Section headings require hairline rule separators and specific capitalization rules.

Do medical devices need special labeling beyond standard FDA requirements?

Yes. Most Class II and Class III medical devices must carry a Unique Device Identifier in both human-readable and AIDC formats under 21 CFR Part 830. Any symbols used must come from FDA-recognized standards like ISO 15223-1, or be defined in a symbols glossary on the label.

Conclusion

Meeting FDA requirements for label design is not a one-time task. Regulations change, new allergens get added, and enforcement activity keeps climbing.

Whether you are managing Nutrition Facts panel formatting, allergen declaration placement, or Drug Facts panel compliance for OTC products, the stakes are the same across every category.

Misbranding violations under the FD&C Act apply per unit. A label error that ships at scale is not a minor issue.

Get the principal display panel, information panel order, and type size requirements right from the start.

Build compliance into your food packaging design process before production, not after. That is where label compliance is cheapest to fix.

• Author
• Recent Posts

Bogdan Sandu

Bogdan Sandu is a seasoned designer who has been designing websites since 2008.

Renowned for his expertise in logo design and visual branding, Bogdan has developed a multitude of logos for various clients.

His skills extend to creating posters, vector illustrations, business cards, and brochures. Additionally, Bogdan's UI kits were featured on marketplaces like Visual Hierarchy and UI8.

He also wrote in the past years on sites like Design Your Way, WebDesignerDepot, WPDean, Designmodo, Speckyboy, Slider Revolution, and more.

Latest posts by Bogdan Sandu (see all)

• The Airtable Logo History, Colors, Font, And Meaning - 12 July 2026
• How to Blur Background in Canva: A Quick Tutorial - 11 July 2026
• Typography Trends - 10 July 2026